Autopsy report · NCT00022490
Imatinib Mesylate Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia
Cause of deathNo reason given
Life of this trial
- Registered 2 months after it had already started.
- Ran for about 10 years 1 month before it stopped.
- 24 participants enrolled.
- Results were posted on the registry 1 year after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- OHSU Knight Cancer Institute
- Sponsor type
- University, hospital or other
- Conditions
- Leukemia
- Interventions
- cytarabine; imatinib mesylate
- Participants
- 24
- Sites
- 2
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.